Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases

Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases

US Patent 8252520 · Granted Aug 28, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer thera2020
RAD51 inhibitors and uses thereof2020
RAD51 inhibitors and uses thereof2019
Small molecule modifiers of the Hec1-Nek2 interaction in G2/M2017
Small molecule modifiers of the HEC1-NEK2 interaction in G2/M2016
Pharmaceutical compositions containing an indoyl isoquinoline containing compoun2015
Pharmaceutical compositions containing an indoyl isoquinoline containing compoun2015
Compositions and methods for disruption of BRCA2-Rad51 interaction2012
Compositions and methods for disruption of BRCA2-Rad51 interaction2012
Method of using an adenoviral vector encoding a retinoblastoma protein to treat 2006
Products and methods for controlling the suppression of the neoplastic phenotype2006
ppRB.sup.110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene pro2000